has been cited by the following article(s):
[1]
|
Long-Term Treatment with Fluvoxamine Decreases Nonmotor Symptoms and Dopamine Depletion in a Postnatal Stress Rat Model of Parkinson’s Disease
Oxidative Medicine and Cellular Longevity,
2020
DOI:10.1155/2020/1941480
|
|
|
[2]
|
Effects of bromelain on motor responses following intra-medial forebrain bundle 6-OHDA injection in rat model of parkinsonism
Metabolic Brain Disease,
2019
DOI:10.1007/s11011-019-00462-9
|
|
|
[3]
|
Early Life Stress, Depression And Parkinson’s Disease: A New Approach
Molecular Brain,
2018
DOI:10.1186/s13041-018-0356-9
|
|
|
[4]
|
Fluvoxamine maleate normalizes striatal neuronal inflammatory cytokine activity in a Parkinsonian rat model associated with depression
Behavioural Brain Research,
2017
DOI:10.1016/j.bbr.2016.08.005
|
|
|
[5]
|
Fluvoxamine maleate effects on dopamine signaling in the prefrontal cortex of stressed Parkinsonian rats: Implications for learning and memory
Brain Research Bulletin,
2017
DOI:10.1016/j.brainresbull.2017.05.014
|
|
|
[6]
|
Anti‐parkinsonian effects of fluvoxamine maleate in maternally separated rats
International Journal of Developmental Neuroscience,
2016
DOI:10.1016/j.ijdevneu.2016.06.004
|
|
|
[7]
|
Anti‐parkinsonian effects of fluvoxamine maleate in maternally separated rats
International Journal of Developmental Neuroscience,
2016
DOI:10.1016/j.ijdevneu.2016.06.004
|
|
|
[8]
|
Exposure to Early Life Stress Results in Epigenetic Changes in Neurotrophic Factor Gene Expression in a Parkinsonian Rat Model
Parkinson's Disease,
2016
DOI:10.1155/2016/6438783
|
|
|